Opioids and postoperative respiratory depression

Why examiners ask this

The post-op section of a stem frequently opens with a nurse calling about a somnolent patient with an SpO2 of 84% on the ward. The examiner wants to see you rescue first and diagnose second, then prevent the next event with multimodal analgesia and the right monitoring. It tests judgment and organization, and the follow-ups about naloxone dosing and renarcotization test application of knowledge.

The 60-second answer

Decision points and the "why"

• Sedation precedes apnea — somnolence and sedation are the most common precursors of opioid-induced ventilatory impairment, appearing before the respiratory rate falls;² I use a sedation scale (POSS) and hold opioids at level 3, frequently drowsy and drifting off mid-conversation.
• Risk factors — obstructive sleep apnea, obesity, age over 65, opioid naivety, renal impairment, concurrent benzodiazepines or gabapentinoids, the first 24 hours after surgery, and continuous basal PCA infusions. I name the ones present and act on them.
• Monitoring — supplemental oxygen delays detection of hypoventilation on pulse oximetry, so a patient on oxygen needs capnography as well.² For high-risk patients I order continuous pulse oximetry with central monitoring and capnography.
• No basal infusion in opioid-naive patients — it adds respiratory depression without improving analgesia. I add acetaminophen, an NSAID, regional anesthesia or ketamine to reduce opioid need.
• Naloxone titration — small increments on the ward; 0.4–2 mg boluses every 2–3 minutes in an arrest, reconsidering the diagnosis if 10 mg produces no response.¹ Its duration is 20–90 minutes, shorter than many opioids and far shorter than methadone, so I watch for renarcotization and start an infusion at two-thirds of the effective dose per hour if needed.³
• Neuraxial morphine — respiratory depression can appear many hours after intrathecal or epidural morphine, so the ASA/ASRA guideline asks for monitoring at least hourly for the first 12 hours, then at least every 2 hours to 24 hours; after single-shot fentanyl, a minimum of 2 hours.⁴
• Renal failure — morphine's active metabolite morphine-6-glucuronide accumulates; I use hydromorphone or fentanyl.

The complication they will inject

I give naloxone 80 mcg and the patient wakes, then 40 minutes later is found apneic again. I recognize renarcotization: the patient had extended-release oxycodone at home and the naloxone has worn off. I ventilate, give another titrated dose, start a naloxone infusion, and move the patient to the ICU or step-down unit. If the patient develops pink frothy sputum and hypoxemia after the reversal, I recognize negative-pressure or catecholamine-mediated pulmonary edema, support with CPAP or reintubation, and give a diuretic if volume overload contributes. I then file a safety report, because a ward arrest on opioids is a system failure as well as a clinical one.

Pitfalls that cost points

• Reaching for naloxone before opening the airway and ventilating.
• Giving 0.4 mg naloxone to a sleepy opioid-tolerant patient with a respiratory rate of 10 and causing withdrawal and uncontrolled pain.
• Assuming opioids are the cause without checking glucose, residual block, CO2 narcosis, stroke or other sedatives.
• Relying on SpO2 while the patient is on 4 L nasal cannula.
• Stopping at the rescue without describing prevention.

Rapid-why

Q: Why does supplemental oxygen hide hypoventilation? A: By raising alveolar oxygen it keeps saturation normal while PaCO2 climbs, so by the time SpO2 falls the patient is severely hypercarbic; the neuraxial guideline warns that routine oxygen can prolong apneic episodes and mask hypoventilation.⁴

Q: Why are patients with sleep apnea at extra risk? A: Opioids blunt the arousal response that ends each obstruction, and REM rebound on nights two and three makes obstruction worse.

Q: Why does sedation predict depression better than respiratory rate? A: The opioid blunts the ventilatory response to CO2 and the patient drifts deeper before the rate falls.

Q: Why does buprenorphine respond poorly to naloxone? A: It binds the mu receptor with high affinity; I need larger doses of naloxone and often ventilatory support.

Numbers to know

Links

• Obstructive sleep apnea (coming), PCA and multimodal analgesia, Acute pain in the opioid-tolerant patient (coming), Residual neuromuscular blockade (coming), Negative-pressure pulmonary edema (coming)
• ASA practice guidelines for the prevention, detection and management of respiratory depression associated with neuraxial opioid administration
• APSF recommendations on continuous postoperative monitoring